LeMaitre Vascular, Inc. (LMAT)
82.93
-1.60
(-1.89%)
USD |
NASDAQ |
Dec 08, 16:00
82.96
+0.04
(+0.04%)
After-Hours: 20:00
LeMaitre Vascular EPS Diluted (Quarterly): 0.7528 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Baxter International, Inc. | 0.0175 |
| Integra LifeSciences Holdings Corp. | -0.0704 |
| ResMed, Inc. | 2.373 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.36M |
| Revenue (Quarterly) | 61.05M |
| Total Expenses (Quarterly) | 43.68M |
| Enterprise Value | 1.724B |
| Gross Profit Margin (Quarterly) | 72.92% |
| Profit Margin (Quarterly) | 28.44% |
| Earnings Yield | 2.80% |
| Operating Earnings Yield | 3.21% |
| Normalized Earnings Yield | 2.804 |